优化青少年和年轻成年人 (AYA) 患急性淋巴细胞白血病的阿斯巴拉基纳斯治疗:美国共识小组建议
Ibrahim Aldoss1, Amir Ali2,3, Ryan D Cassaday4,5
1Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
American journal of hematology
|October 11, 2025
概括
青少年和年轻成人 (AYA) 患者急性淋巴细胞白血病的阿斯巴拉基纳斯治疗面临着挑战. 专家建议旨在改善接受这些儿科启发方案的AYA患者的获取,安全和结果.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 儿科瘤学 儿科瘤学
背景情况:
- 阿斯巴拉金酶对于儿科急性淋巴细胞白血病 (ALL) 和淋巴细胞淋巴瘤 (LBL) 非常重要.
- 与阿斯帕拉金酶的儿科启发方案对青少年和年轻成年人 (AYA) 和成人ALL/LBL患者有希望,与成人协议相比,改善了结果.
- AYA患者在这些先进的治疗方法中遇到不同的挑战.
研究的目的:
- 为了确定在给AYA患者使用阿斯巴拉金酶治疗时存在的障碍和可行性问题.
- 提供专家建议,以优化AYA患者的治疗结果和这些治疗方案的经验.
- 为了提高阿斯巴拉基纳斯治疗对AYA人群的可访问性和安全性.
主要方法:
- 一个由专家组成的共识小组确定了AYA患者在阿斯巴拉基纳斯治疗中的挑战.
- 分析障碍,包括临床试验准入,毒性管理,设施限制和心理社会因素.
- 制定建议,以应对已确定的挑战.
主要成果:
- 关键障碍包括儿童启发的治疗方案和AYA患者的试验的有限访问.
- 复杂的阿斯巴拉金酶毒性管理和医疗基础设施不足构成了重大障碍.
- 心理社会和生活方式因素对AYA患者的坚持和治疗机会产生负面影响.
结论:
- 解决障碍对于改善AYA患者的阿斯巴拉基纳斯治疗可及性和安全性至关重要.
- 为接受阿斯巴拉基纳斯治疗的高风险AYA人群提出了具体建议.
- 优化护理途径可以提高AYA ALL/LBL患者的临床结果和患者体验.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
192
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
192